JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

First published online January 21, 2009, 10.2967/jnumed.108.056556
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.108.056556v1
50/2/303    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, N.
Right arrow Articles by Yu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, N.
Right arrow Articles by Yu, J.
Journal of Nuclear Medicine Vol. 50 No. 2 303-308
© 2009 by Society of Nuclear Medicine
doi: 10.2967/jnumed.108.056556

Basic Science Investigation

PET-Based Biodistribution and Radiation Dosimetry of Epidermal Growth Factor Receptor–Selective Tracer 11C-PD153035 in Humans

Ningbo Liu1, Minghuan Li2, Xiaoyu Li3, Xue Meng2, Guoren Yang4, Shuqiang Zhao4, Yi Yang5, Li Ma4, Zheng Fu4 and Jinming Yu1,2

1 Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; 2 Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, China; 3 Department of Pathophysiology, Nanjing Medical University, Nanjing, China; 4 PET-CT Center, Shandong Cancer Hospital and Institute, Jinan China; and 5 Department of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China

Correspondence: For correspondence or reprints contact: Jinming Yu, Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jiyan Rd. 440, Jinan 250117, Shandong Province, P.R. China. E-mail: studyhard8{at}sohu.com

The present study estimated the biodistribution and radiation-absorbed dose of epidermal growth factor receptor (EGFR) radioligand 11C-PD153035 in whole-body PET examinations of healthy volunteers. Methods: Two-dimensional whole-body PET was performed on 9 subjects after injection of 11C-PD153035 at 329.3 ± 77.8 MBq (mean ± SD). A total of 12 frames were acquired for approximately 90 min in 7 segments of the body. Regions of interest were drawn on PET images of source organs. Residence time was calculated as the area under the time–activity curve. Radiation dosimetry was calculated from organ residence time by use of MIRDOSE3 software. Results: The renal and hepatobiliary systems played important roles in 11C-PD153035 excretion from the body, accounting for the excretion of approximately 23% and 19% of the injected radioactivity, respectively. Blood-pool activity was only moderate and declined over time. Tracer accumulation in the lungs, bone marrow, and muscles was slight, resulting in low background activity in the chest. The organs with the highest radiation-absorbed doses were the urinary bladder and the gallbladder; the effective doses were 6.08E–02 ± 1.85E–02 and 2.40E–02 ± 8.01E–03 mGy/MBq, respectively. The effective dose equivalent was 7.43E–03 ± 1.10E–03 mSv/MBq, and the dose-limiting organ was the urinary bladder. Conclusion: On the basis of the estimated absorbed dose, 11C-PD153035 displayed a favorable radiation dose profile in humans and therefore could be used in multiple PET examinations of the same subject per year. 11C-PD153035 is a promising ligand for the investigation of EGFR in humans, especially in chest tumors such as non–small cell lung cancer.

Key Words: 11C-PD153035 • PET • EGFR • molecular imaging • dosimetry

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]  



This article has been cited by other articles:


Home page
 JNMHome page
E. Mishani and A. Hagooly
Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer
J. Nucl. Med., August 1, 2009; 50(8): 1199 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
L. Ningbo, Y. Jinming, M. Xue, and S. Jian
Reply: Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression
J. Nucl. Med., July 1, 2009; 50(7): 1197 - 1198.
[Full Text] [PDF]

Home page
 JNMHome page
M. A Pantaleo, M. Nannini, S. Fanti, S. Boschi, P.-L. Lollini, and G. Biasco
Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression
J. Nucl. Med., July 1, 2009; 50(7): 1195 - 1196.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.